<- Go Home
ASP Isotopes Inc.
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
Market Cap
$377.7M
Volume
670.3K
Cash and Equivalents
$51.6M
EBITDA
-$22.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.1M
Profit Margin
33.48%
52 Week High
$9.33
52 Week Low
$1.86
Dividend
N/A
Price / Book Value
9.35
Price / Earnings
-8.69
Price / Tangible Book Value
10.27
Enterprise Value
$365.3M
Enterprise Value / EBITDA
-16.84
Operating Income
-$22.7M
Return on Equity
108.08%
Return on Assets
-29.60
Cash and Short Term Investments
$51.6M
Debt
$35.9M
Equity
$42.0M
Revenue
$3.4M
Unlevered FCF
-$14.1M
Sector
Chemicals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium